These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26148930)

  • 1. A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure.
    Perin EC; Borow KM; Silva GV; DeMaria AN; Marroquin OC; Huang PP; Traverse JH; Krum H; Skerrett D; Zheng Y; Willerson JT; Itescu S; Henry TD
    Circ Res; 2015 Aug; 117(6):576-84. PubMed ID: 26148930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracoronary infusion of allogeneic mesenchymal precursor cells directly after experimental acute myocardial infarction reduces infarct size, abrogates adverse remodeling, and improves cardiac function.
    Houtgraaf JH; de Jong R; Kazemi K; de Groot D; van der Spoel TI; Arslan F; Hoefer I; Pasterkamp G; Itescu S; Zijlstra F; Geleijnse ML; Serruys PW; Duckers HJ
    Circ Res; 2013 Jul; 113(2):153-66. PubMed ID: 23658436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic mesenchymal precursor cells (MPCs): an innovative approach to treating advanced heart failure.
    Westerdahl DE; Chang DH; Hamilton MA; Nakamura M; Henry TD
    Expert Opin Biol Ther; 2016 Sep; 16(9):1163-9. PubMed ID: 27376188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reparative effects of allogeneic mesenchymal precursor cells delivered transendocardially in experimental nonischemic cardiomyopathy.
    Psaltis PJ; Carbone A; Nelson AJ; Lau DH; Jantzen T; Manavis J; Williams K; Itescu S; Sanders P; Gronthos S; Zannettino AC; Worthley SG
    JACC Cardiovasc Interv; 2010 Sep; 3(9):974-83. PubMed ID: 20850099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial.
    Yau TM; Pagani FD; Mancini DM; Chang HL; Lala A; Woo YJ; Acker MA; Selzman CH; Soltesz EG; Kern JA; Maltais S; Charbonneau E; Pan S; Marks ME; Moquete EG; O'Sullivan KL; Taddei-Peters WC; McGowan LK; Green C; Rose EA; Jeffries N; Parides MK; Weisel RD; Miller MA; Hung J; O'Gara PT; Moskowitz AJ; Gelijns AC; Bagiella E; Milano CA;
    JAMA; 2019 Mar; 321(12):1176-1186. PubMed ID: 30912838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices.
    Ascheim DD; Gelijns AC; Goldstein D; Moye LA; Smedira N; Lee S; Klodell CT; Szady A; Parides MK; Jeffries NO; Skerrett D; Taylor DA; Rame JE; Milano C; Rogers JG; Lynch J; Dewey T; Eichhorn E; Sun B; Feldman D; Simari R; O'Gara PT; Taddei-Peters WC; Miller MA; Naka Y; Bagiella E; Rose EA; Woo YJ
    Circulation; 2014 Jun; 129(22):2287-96. PubMed ID: 24682346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.
    Bartunek J; Behfar A; Dolatabadi D; Vanderheyden M; Ostojic M; Dens J; El Nakadi B; Banovic M; Beleslin B; Vrolix M; Legrand V; Vrints C; Vanoverschelde JL; Crespo-Diaz R; Homsy C; Tendera M; Waldman S; Wijns W; Terzic A
    J Am Coll Cardiol; 2013 Jun; 61(23):2329-38. PubMed ID: 23583246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.
    Hare JM; Fishman JE; Gerstenblith G; DiFede Velazquez DL; Zambrano JP; Suncion VY; Tracy M; Ghersin E; Johnston PV; Brinker JA; Breton E; Davis-Sproul J; Schulman IH; Byrnes J; Mendizabal AM; Lowery MH; Rouy D; Altman P; Wong Po Foo C; Ruiz P; Amador A; Da Silva J; McNiece IK; Heldman AW; George R; Lardo A
    JAMA; 2012 Dec; 308(22):2369-79. PubMed ID: 23117550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure.
    Perin EC; Silva GV; Zheng Y; Gahremanpour A; Canales J; Patel D; Fernandes MR; Keller LH; Quan X; Coulter SA; Moore WH; Herlihy JP; Willerson JT
    Am Heart J; 2012 Mar; 163(3):415-21, 421.e1. PubMed ID: 22424012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure.
    Qayyum AA; Mouridsen M; Nilsson B; Gustafsson I; Schou M; Nielsen OW; Hove JD; Mathiasen AB; Jørgensen E; Helqvist S; Joshi FR; Johansen EM; Follin B; Juhl M; Højgaard LD; Haack-Sørensen M; Ekblond A; Kastrup J
    ESC Heart Fail; 2023 Apr; 10(2):1170-1183. PubMed ID: 36638837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study).
    Florea V; Rieger AC; DiFede DL; El-Khorazaty J; Natsumeda M; Banerjee MN; Tompkins BA; Khan A; Schulman IH; Landin AM; Mushtaq M; Golpanian S; Lowery MH; Byrnes JJ; Hendel RC; Cohen MG; Valasaki K; Pujol MV; Ghersin E; Miki R; Delgado C; Abuzeid F; Vidro-Casiano M; Saltzman RG; DaFonseca D; Caceres LV; Ramdas KN; Mendizabal A; Heldman AW; Mitrani RD; Hare JM
    Circ Res; 2017 Nov; 121(11):1279-1290. PubMed ID: 28923793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure.
    Borow KM; Yaroshinsky A; Greenberg B; Perin EC
    Circ Res; 2019 Jul; 125(3):265-281. PubMed ID: 31318648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure.
    Perin EC; Borow KM; Henry TD; Mendelsohn FO; Miller LW; Swiggum E; Adler ED; Chang DH; Fish RD; Bouchard A; Jenkins M; Yaroshinsky A; Hayes J; Rutman O; James CW; Rose E; Itescu S; Greenberg B
    J Am Coll Cardiol; 2023 Mar; 81(9):849-863. PubMed ID: 36858705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
    Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
    JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter-based endomyocardial delivery of mesenchymal precursor cells using 3D echo guidance improves cardiac function in a chronic myocardial injury ovine model.
    Cheng Y; Yi G; Conditt GB; Sheehy A; Kolodgie FD; Tellez A; Polyakov I; Gu A; Aboodi MS; Wallace-Bradley D; Schuster M; Martens T; Itescu S; Kaluza GL; Basu S; Virmani R; Granada JF; Sherman W
    Cell Transplant; 2013; 22(12):2299-309. PubMed ID: 23107489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration.
    Natsumeda M; Florea V; Rieger AC; Tompkins BA; Banerjee MN; Golpanian S; Fritsch J; Landin AM; Kashikar ND; Karantalis V; Loescher VY; Hatzistergos KE; Bagno L; Sanina C; Mushtaq M; Rodriguez J; Rosado M; Wolf A; Collon K; Vincent L; Kanelidis AJ; Schulman IH; Mitrani R; Heldman AW; Balkan W; Hare JM
    J Am Coll Cardiol; 2017 Nov; 70(20):2504-2515. PubMed ID: 29145950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit
    Bolli R; Hare JM; March KL; Pepine CJ; Willerson JT; Perin EC; Yang PC; Henry TD; Traverse JH; Mitrani RD; Khan A; Hernandez-Schulman I; Taylor DA; DiFede DL; Lima JAC; Chugh A; Loughran J; Vojvodic RW; Sayre SL; Bettencourt J; Cohen M; Moyé L; Ebert RF; Simari RD;
    Circ Res; 2018 Jun; 122(12):1703-1715. PubMed ID: 29703749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic Precursor Cells for Systolic Heart Failure: A Need for Mechanisms in Humans.
    Farris S; Stempien-Otero A
    Circ Res; 2015 Aug; 117(6):494-7. PubMed ID: 26316605
    [No Abstract]   [Full Text] [Related]  

  • 19. Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy.
    Trachtenberg B; Velazquez DL; Williams AR; McNiece I; Fishman J; Nguyen K; Rouy D; Altman P; Schwarz R; Mendizabal A; Oskouei B; Byrnes J; Soto V; Tracy M; Zambrano JP; Heldman AW; Hare JM
    Am Heart J; 2011 Mar; 161(3):487-93. PubMed ID: 21392602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryopreserved Off-the-Shelf Allogeneic Adipose-Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure-A Safety Study.
    Kastrup J; Haack-Sørensen M; Juhl M; Harary Søndergaard R; Follin B; Drozd Lund L; Mønsted Johansen E; Ali Qayyum A; Bruun Mathiasen A; Jørgensen E; Helqvist S; Jørgen Elberg J; Bruunsgaard H; Ekblond A
    Stem Cells Transl Med; 2017 Nov; 6(11):1963-1971. PubMed ID: 28880460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.